Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 29, 2015

 

 

XYLEM INC.

(Exact name of registrant as specified in its charter)

 

 

 

Indiana   001-35229   45-2080495

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

1 International Drive

Rye Brook, New York

  10573
(Address of principal executive offices)   (Zip Code)

(914) 323-5700

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02 Results of Operations and Financial Condition

On October 29, 2015, Xylem Inc. issued a press release announcing its financial results for the third quarter and nine months ended September 30, 2015. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated by reference herein.

This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

 

Exhibit

No.

   Description
99.1    Press Release issued by Xylem Inc. on October 29, 2015.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    XYLEM INC.
Date: October 29, 2015     By:  

/s/ Shashank Patel

      Shashank Patel
     

Interim Chief Financial Officer

(Authorized Officer of Registrant)


EXHIBIT INDEX

 

Exhibit
No.
   Description
99.1    Press Release issued by Xylem Inc. on October 29, 2015.
EX-99.1

Exhibit 99.1

 

LOGO

Xylem Inc.

1 International Drive, Rye Brook N.Y. 10573

Tel +1.914.323.5700 Fax +1.914.696.2960

 

Contacts:   Media    Investors
  Kelly McAndrew +1 (914) 323-5969    Phil DeSousa +1 (914) 323-5930
  Kelly.McAndrew@xyleminc.com    Phil.DeSousa@xyleminc.com

Xylem Inc. reports solid top-line and adjusted earnings growth

in third quarter 2015

 

    Third quarter 2015 revenue was $902 million, an increase of two percent on an organic basis

 

    Third quarter 2015 adjusted net income was $90 million or $0.49 per share, which excluding foreign exchange translation impact, was up four percent over third quarter 2014 results; GAAP net income was $88 million or $0.48 per share, down 17 percent year-over-year

 

    Company reaffirms organic revenue growth and adjusted EPS guidance for full-year 2015

RYE BROOK, N.Y., October 29, 2015 – Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported third quarter 2015 net income of $88 million, or $0.48 per share. Excluding restructuring and realignment charges and other special items, adjusted net income was $90 million or $0.49 per share, down eight percent from the comparable period in 2014, but up four percent excluding foreign exchange translation impact. Third quarter revenue was $902 million, an increase of two percent organically, reflecting strength in the public utility end market. Third quarter operating margin, adjusted to exclude restructuring and realignment charges, was 13.7 percent, down 20 basis points from the prior year, however, this result was flat year-over-year excluding foreign exchange translation.

“Our team delivered solid results this quarter, with project deliveries driving better than expected performance,” said Patrick Decker, Xylem President and Chief Executive Officer. “We are continuing to see signs of increasing strength in the public utility end market and mixed conditions in industrials. We continue to grow and expand our business in emerging markets, where we generated a nine-percent increase in organic revenue in the quarter. While we did see some growth deceleration in the commercial building and industrial sectors, these regions, such as China and India, are continuing to increase investments in water and wastewater infrastructure. In India, for example, we recently secured a $39 million order for a custom pumping system that will provide drinking water and irrigation to arid areas that currently do not have stable water sources.”

Decker continued, “We are executing a balanced capital deployment strategy. During the quarter, we opportunistically repurchased $75 million in shares and, last week, we added a new business to our analytics portfolio that strengthens our offering. We will continue to maintain a sharp focus on execution across all aspects of our business as we close out the year.”


During the third quarter 2015, Xylem repurchased 2.3 million shares of common stock under its stock repurchase programs. As of September 30, 2015, Xylem had approximately $475 million remaining under its current stock repurchase authorizations.

Full-year 2015 Outlook

Xylem continues to expect full-year 2015 revenue of approximately $3.7 billion, a decrease of six to seven percent from the full-year 2014 results. On an organic basis, Xylem also continues to expect to generate revenue growth of approximately one to two percent.

Expectations for full-year 2015 adjusted earnings per share continue to be in the range of $1.82 to $1.87. Excluding the projected unfavorable impact of foreign exchange translation, Xylem’s adjusted earnings per share growth expectations are in the range of four to seven percent over the comparable full-year 2014 results. The Company’s outlook for projected restructuring and realignment costs of $20 million for the year is unchanged.

Third Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its businesses serving clean water delivery, wastewater transport and treatment, dewatering and analytical instrumentation.

 

    Third quarter 2015 Water Infrastructure revenue was $551 million, up two percent relative to the prior year period on an organic basis. This increase was driven by five-percent growth in the public utility end market, reflecting strong growth in the United States and Europe, as well as continued infrastructure investment activity in emerging markets.

 

    Third quarter adjusted segment operating income was $85 million, down $13 million from the prior year result, reflecting the unfavorable impact of foreign exchange translation. Operating income for the quarter was $83 million, down $12 million from last year. Adjusted operating margin for the quarter decreased 90 basis points to 15.4 percent as the impact of strong procurement and lean cost savings was more than offset by investment in strategic growth initiatives, unfavorable mix and inflation.

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in residential and commercial building services, and industrial and agricultural applications.

 

    Third quarter 2015 revenue was $351 million, an increase of three percent organically compared with the third quarter 2014. Growth in residential and commercial building applications, as well as industrial project deliveries helped to drive this improvement. Xylem’s business in emerging markets showed continued strength, despite the expected slow-down in China, and North America and Europe each delivered modest growth.

 

    Adjusted segment operating income was $48 million in the third quarter, down $4 million from the comparable period last year, reflecting the unfavorable impact of foreign exchange translation. Operating income was $46 million, which was $5 million lower than last year. Adjusted operating margin for the quarter decreased 70 basis points to 13.7 percent as strong procurement and lean cost savings were more than offset by the impacts of foreign exchange translation, unfavorable mix and inflation.


Supplemental information on Xylem’s third quarter earnings and reconciliations for non-GAAP items are posted at http://investors.xyleminc.com.

About Xylem

Xylem (XYL) is a leading global water technology provider, enabling customers to transport, treat, test and efficiently use water in public utility, residential and commercial building services, industrial and agricultural settings. The Company does business in more than 150 countries through a number of market-leading product brands, and its people bring broad applications expertise with a strong focus on finding local solutions to the world’s most challenging water and wastewater problems. Xylem is headquartered in Rye Brook, New York, with 2014 revenues of $3.9 billion and approximately 12,500 employees worldwide. Xylem was named to the Dow Jones Sustainability Index for the last four years for advancing sustainable business practices and solutions worldwide and the Company has satisfied the requirements to be a constituent of the FTSE4Good Index Series each year since 2013.

The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all – that which occurs in nature. For more information, please visit us at www.xylem.com.

Forward-Looking Statements

This press release contains information that may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “believe,” “target,” “will,” “could,” “would,” “should” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. These forward-looking statements include statements about the capitalization of the Company, the Company’s restructuring and realignment, future strategic plans and other statements that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals. All statements that address operating or financial performance, events or developments that we expect or anticipate will occur in the future - including statements relating to orders, revenue, operating margins and earnings per share growth, and statements expressing general views about future operating results - are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such forward-looking statements.

Factors that could cause results to differ materially from those anticipated include: economic, political and other risks associated with our international operations, including military actions, economic sanctions or trade embargoes that could affect customer markets, and non-compliance with laws, including foreign corrupt practice laws, export and import laws and competition laws; potential for unexpected cancellations or delays of customer orders in our reported backlog; our exposure to fluctuations in foreign currency exchange rates; competition and pricing pressures in the markets we serve; the strength of housing and related markets; weather conditions; ability to retain and attract key members of management; our relationship with and the performance of our channel partners; our ability to borrow or to refinance our


existing indebtedness and availability of liquidity sufficient to meet our needs; changes in the value of goodwill or intangible assets; risks relating to product defects, product liability and recalls; governmental investigations; security breaches or other disruptions of our information technology systems; litigation and contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2014 and with subsequent filings we make with the Securities and Exchange Commission.

All forward-looking statements made herein are based on information available to the Company as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.


XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)

 

     Three Months      Nine Months  

For the periods ended September 30,

   2015      2014      2015      2014  

Revenue

   $ 902       $ 963       $ 2,659       $ 2,874   

Cost of revenue

     551         587         1,645         1,768   
  

 

 

    

 

 

    

 

 

    

 

 

 

Gross profit

     351         376         1,014         1,106   

Selling, general and administrative expenses

     207         222         631         688   

Research and development expenses

     23         24         71         78   

Restructuring charges

     1         —           5         18   
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating income

     120         130         307         322   

Interest expense

     13         14         41         41   

Other non-operating income, net

     —           1         —           1   

Gain from sale of businesses

     —           11         9         11   
  

 

 

    

 

 

    

 

 

    

 

 

 

Income before taxes

     107         128         275         293   

Income tax expense

     19         22         49         52   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 88       $ 106       $ 226       $ 241   
  

 

 

    

 

 

    

 

 

    

 

 

 

Earnings per share:

           

Basic

   $ 0.48       $ 0.58       $ 1.25       $ 1.31   

Diluted

   $ 0.48       $ 0.58       $ 1.24       $ 1.31   

Weighted average number of shares:

           

Basic

     180.8         182.2         181.5         183.4   

Diluted

     181.6         183.4         182.3         184.6   

Dividends declared per share

   $ 0.1408       $ 0.1280       $ 0.4224       $ 0.3840   


XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except per share amounts)

 

     September 30,
2015
    December 31,
2014
 

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 611      $ 663   

Receivables, less allowances for discounts and doubtful accounts of $29 and $34 in 2015 and 2014, respectively

     762        771   

Inventories

     477        486   

Prepaid and other current assets

     132        144   

Deferred income tax assets

     35        38   
  

 

 

   

 

 

 

Total current assets

     2,017        2,102   

Property, plant and equipment, net

     418        461   

Goodwill

     1,584        1,635   

Other intangible assets, net

     434        470   

Other non-current assets

     192        192   
  

 

 

   

 

 

 

Total assets

   $ 4,645      $ 4,860   
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current liabilities:

    

Accounts payable

   $ 314      $ 338   

Accrued and other current liabilities

     422        481   

Short-term borrowings and current maturities of long-term debt

     79        89   
  

 

 

   

 

 

 

Total current liabilities

     815        908   

Long-term debt

     1,196        1,195   

Accrued postretirement benefits

     374        388   

Deferred income tax liabilities

     141        158   

Other non-current accrued liabilities

     76        84   
  

 

 

   

 

 

 

Total liabilities

     2,602        2,733   
  

 

 

   

 

 

 

Stockholders’ equity:

    

Common Stock – par value $0.01 per share:

    

Authorized 750.0 shares, issued 189.8 shares and 188.9 shares in 2015 and 2014, respectively

     2        2   

Capital in excess of par value

     1,822        1,796   

Retained earnings

     796        648   

Treasury stock – at cost 10.4 shares and 6.6 shares in 2015 and 2014, respectively

     (348     (220

Accumulated other comprehensive loss

     (229     (99
  

 

 

   

 

 

 

Total stockholders’ equity

     2,043        2,127   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 4,645      $ 4,860   
  

 

 

   

 

 

 


XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

 

For the nine months ended September 30,

   2015     2014  

Operating Activities

    

Net income

   $ 226      $ 241   

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation

     69        70   

Amortization

     33        37   

Share-based compensation

     11        14   

Restructuring charges

     5        18   

Gain from sale of businesses

     (9     (11

Other, net

     10        (2

Payments for restructuring

     (11     (20

Changes in assets and liabilities (net of acquisitions):

    

Changes in receivables

     (32     (40

Changes in inventories

     (15     (62

Changes in accounts payable

     6        (2

Other, net

     (33     10   
  

 

 

   

 

 

 

Net Cash – Operating activities

     260        253   
  

 

 

   

 

 

 

Investing Activities

    

Capital expenditures

     (78     (77

Proceeds from sale of businesses

     1        30   

Proceeds from the sale of property, plant and equipment

     1        2   

Other, net

     2        —     
  

 

 

   

 

 

 

Net Cash – Investing activities

     (74     (45
  

 

 

   

 

 

 

Financing Activities

    

(Repayment) issuance of short-term debt

     (3     2   

Repurchase of common stock

     (128     (132

Proceeds from exercise of employee stock options

     14        17   

Dividends paid

     (77     (71

Other, net

     —          2   
  

 

 

   

 

 

 

Net Cash – Financing activities

     (194     (182
  

 

 

   

 

 

 

Effect of exchange rate changes on cash

     (44     (30
  

 

 

   

 

 

 

Net change in cash and cash equivalents

     (52     (4

Cash and cash equivalents at beginning of year

     663        533   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 611      $ 529   
  

 

 

   

 

 

 

Supplemental disclosure of cash flow information:

    

Cash paid during the period for:

    

Interest

   $ 37      $ 36   

Income taxes (net of refunds received)

   $ 57      $ 69   


Xylem Inc. Non-GAAP Measures

Management views key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, free cash flow, working capital, and backlog, among others. In addition, we consider certain measures to be useful to management and investors evaluating our operating performance for the periods presented, and provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operations as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:

“Organic revenue” and “Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales of portions of our business that did not meet the criteria for classification as a discontinued operation or insignificant portions of our business that we did not classify as a discontinued operation. The period-over-period change resulting from foreign currency fluctuations assumes no change in exchange rates from the prior period.

“Constant currency” defined as financial results adjusted for currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

“EBITDA” defined as earnings before interest, taxes, depreciation, amortization expense, and share-based compensation. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude restructuring and realignment costs, gain on sale of business and special charges.

“Adjusted Operating Income”, “Adjusted Segment Operating Income”, and “Adjusted EPS” defined as operating income, segment operating income and earnings per share, adjusted to exclude restructuring and realignment costs, gain on sale of businesses, special charges and tax-related special items, as applicable.

“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of free cash flows does not consider non-discretionary cash payments, such as debt.

“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

“Special charges” defined as costs incurred by the Company, such as legal and professional fees, associated with the Korea matters, as well as costs incurred for the contractual indemnification of tax obligations to ITT.

“Tax-related special items” defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts and other discrete tax adjustments.


Xylem Inc. Non-GAAP Reconciliation

Reported vs. Organic & Constant Currency Orders

($ Millions)

 

    (As Reported - GAAP)     (As Adjusted - Organic)     Constant Currency  
          (A)     (B)           (C)     (D)     (E) = B+C+D     (F) = E/A     (G) = (E - C) / A  
    Orders     Orders     Change
2015 v. 2014
    % Change
2015 v. 2014
    Acquisitions /
Divestitures
    FX Contribution     Change
Adj. 2015 v. 2014
    % Change
Adj. 2015 v. 2014
       
    2015     2014                                            

Nine Months Ended September 30

                 

Xylem Inc.

    2,798        3,051        (253     -8     10        257        14        0     0

Water Infrastructure

    1,737        1,915        (178     -9     —          192        14        1     1

Applied Water

    1,061        1,136        (75     -7     10        65        —          0     -1

Quarter Ended September 30

                 

Xylem Inc.

    939        1,027        (88     -9     —          88        —          0     0

Water Infrastructure

    590        664        (74     -11     —          68        (6     -1     -1

Applied Water

    349        363        (14     -4     —          20        6        2     2

Quarter Ended June 30

                 

Xylem Inc.

    944        1,031        (87     -8     5        92        10        1     0

Water Infrastructure

    585        654        (69     -11     —          69        —          0     0

Applied Water

    359        377        (18     -5     5        24        11        3     2

Quarter Ended March 31

                 

Xylem Inc.

    915        993        (78     -8     5        77        4        0     0

Water Infrastructure

    562        597        (35     -6     —          55        20        3     3

Applied Water

    353        396        (43     -11     5        21        (17     -4     -6


Xylem Inc. Non-GAAP Reconciliation

Reported vs. Organic & Constant Currency Revenue

($ Millions)

 

    (As Reported - GAAP)     (As Adjusted - Organic)     Constant Currency  
          (A)     (B)           (C)     (D)     (E) = B+C+D     (F) = E/A     (G) = (E - C) / A  
                Change     % Change     Acquisitions /           Change     % Change        
    Revenue     Revenue     2015 v. 2014     2015 v. 2014     Divestitures     FX Contribution     Adj. 2015 v. 2014     Adj. 2015 v. 2014        
    2015     2014                                            

Nine Months Ended September 30

                 

Xylem Inc.

    2,659        2,874        (215     -7     11        243        39        1     1

Water Infrastructure

    1,602        1,770        (168     -9     —          180        12        1     1

Applied Water

    1,057        1,104        (47     -4     11        63        27        2     1

Quarter Ended September 30

                 

Xylem Inc.

    902        963        (61     -6     —          81        20        2     2

Water Infrastructure

    551        602        (51     -8     —          61        10        2     2

Applied Water

    351        361        (10     -3     —          20        10        3     3

Quarter Ended June 30

                 

Xylem Inc.

    920        1,005        (85     -8     6        89        10        1     0

Water Infrastructure

    551        616        (65     -11     —          65        —          0     0

Applied Water

    369        389        (20     -5     6        24        10        3     1

Quarter Ended March 31

                 

Xylem Inc.

    837        906        (69     -8     5        73        9        1     0

Water Infrastructure

    500        552        (52     -9     —          54        2        0     0

Applied Water

    337        354        (17     -5     5        19        7        2     1


Xylem Inc. Non-GAAP Reconciliation

Adjusted Operating Income

($ Millions)

 

     Q1     Q2     Q3     YTD  
     2015     2014     2015     2014     2015     2014     2015     2014  

Total Revenue

                

• Total Xylem

     837        906        920        1,005        902        963        2,659        2,874   

• Water Infrastructure

     500        552        551        616        551        602        1,602        1,770   

• Applied Water

     337        354        369        389        351        361        1,057        1,104   

Operating Income

                

• Total Xylem

     83        76        104        116        120        130        307        322   

• Water Infrastructure

     47        46        65        76        83        95        195        217   

• Applied Water

     46        41        51        53        46        51        143        145   

• Total Segments

     93        87        116        129        129        146        338        362   

Operating Margin

                

• Total Xylem

     9.9     8.4     11.3     11.5     13.3     13.5     11.5     11.2

• Water Infrastructure

     9.4     8.3     11.8     12.3     15.1     15.8     12.2     12.3

• Applied Water

     13.6     11.6     13.8     13.6     13.1     14.1     13.5     13.1

• Total Segments

     11.1     9.6     12.6     12.8     14.3     15.2     12.7     12.6

Special Charges

                

• Total Xylem

     1        —          —          —          —          —          1        —     

• Water Infrastructure

     1        —          —          —          —          —          1        —     

• Applied Water

     —          —          —          —          —          —          —          —     

• Total Segments

     1        —          —          —          —          —          1        —     

Restructuring & Realignment Costs

                

• Total Xylem

     6        18        6        9        4        4        16        31   

• Water Infrastructure

     5        12        4        5        2        3        11        20   

• Applied Water

     1        6        2        4        2        1        5        11   

• Total Segments

     6        18        6        9        4        4        16        31   

Adjusted Operating Income*

                

• Total Xylem

     90        94        110        125        124        134        324        353   

• Water Infrastructure

     53        58        69        81        85        98        207        237   

• Applied Water

     47        47        53        57        48        52        148        156   

• Total Segments

     100        105        122        138        133        150        355        393   

Adjusted Operating Margin*

                

• Total Xylem

     10.8     10.4     12.0     12.4     13.7     13.9     12.2     12.3

• Water Infrastructure

     10.6     10.5     12.5     13.1     15.4     16.3     12.9     13.4

• Applied Water

     13.9     13.3     14.4     14.7     13.7     14.4     14.0     14.1

• Total Segments

     11.9     11.6     13.3     13.7     14.7     15.6     13.4     13.7

 

* Adjusted Operating Income excludes restructuring & realignment costs and special charges.


Xylem Inc. Non-GAAP Reconciliation

Adjusted Diluted EPS

($ Millions, except per share amounts)

 

     Q3 2014     Q3 2015  
     As Reported     Adjustments            Adjusted     As Reported     Adjustments            Adjusted  

Total Revenue

     963             963        902             902   

Operating Income

     130        4        a         134        120        4        a         124   

Operating Margin

     13.5          13.9     13.3          13.7

Interest Expense

     (14          (14     (13          (13

Other Non-Operating Income (Expense)

     1             1        —          2        b         2   

Gain from sale of business

     11        (11        —          —          —             —     
  

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Income before Taxes

     128        (7        121        107        6           113   

Provision for Income Taxes

     (22     (2     c         (24     (19     (4     c         (23
  

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Net Income

     106        (9        97        88        2           90   
  

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Diluted Shares

     183.4             183.4        181.6             181.6   

Diluted EPS

   $ 0.58      $ (0.05      $ 0.53      $ 0.48      $ 0.01         $ 0.49   

Currency translation impact on current year diluted EPS

            $ (0.06        $ (0.06

Diluted EPS at Constant Currency

            $ 0.54           $ 0.55   
     Q3 YTD 2014     Q3 YTD 2015  
     As Reported     Adjustments            Adjusted     As Reported     Adjustments            Adjusted  

Total Revenue

     2,874             2,874        2,659             2,659   

Operating Income

     322        31        a         353        307        17        a         324   

Operating Margin

     11.2          12.3     11.5          12.2

Interest Expense

     (41          (41     (41          (41

Other Non-Operating Income (Expense)

     1             1        —          4        b         4   

Gain from sale of businesses

     11        (11        —          9        (9        0   
  

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Income before Taxes

     293        20           313        275        12           287   

Provision for Income Taxes

     (52     (13     c         (65     (49     (10     c         (59
  

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Net Income

     241        7           248        226        2           228   
  

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Diluted Shares

     184.6             184.6        182.3             182.3   

Diluted EPS

   $ 1.31      $ 0.04         $ 1.35      $ 1.24      $ 0.01         $ 1.25   

Currency translation impact on current year diluted EPS

            $ (0.17        $ (0.17

Diluted EPS at Constant Currency

            $ 1.41           $ 1.42   

 

a Restructuring & realignment costs in 2014 and 2015 and special charges in 2015
b Special charges
c Net tax impact of restructuring & realignment costs and special charges, and tax-related special items


Xylem Inc. Non-GAAP Reconciliation

Net Cash - Operating Activities vs. Free Cash Flow

($ Millions)

 

     Q1     Q2     Q3     Nine Months Ended  
     2015     2014     2015     2014     2015     2014     2015     2014  

Net Cash - Operating Activities

   $ 39      $ 22      $ 84      $ 76      $ 137      $ 155      $ 260      $ 253   

Capital Expenditures

     (37     (25     (20     (23     (21     (29     (78     (77
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Free Cash Flow

   $ 2      $ (3   $ 64      $ 53      $ 116      $ 126      $ 182      $ 176   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Income

     64        49        74        86        88        106        226        241   

Gain from sale of businesses

     9        —          —          —          —          11        9        11   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Income, excluding gain on sale of businesses

   $ 55      $ 49      $ 74      $ 86      $ 88      $ 95      $ 217      $ 230   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Free Cash Flow Conversion

     4     -6     86     62     132     133     84     77